tirzepatide w (Month 1) 2.5mg changing treatment that can accelerate your weight loss journey and help you achieve lasting results. How the weight loss drug
Description
Data from SURMOUNT-1 (NEJM, 2022), STEP-1 (NEJM, 2021), SCALE (NEJM, 2015)
Retatrutide adds glucagon-receptor activity to the GLP-1 and GIP that tirzepatide already targets
Hannbeck added that the situation surrounding Mounjaro should be a wake-up call for policymakers
Key Differences Between Retatrutide and Tirzepatide 1
Administration of GLP- 1 receptor agonists reduces appetite, decreases energy intake, and increases satiety
